Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Carrier

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Cardiovascular Research|November 5, 2015
Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathyFrederik Flenner, Felix W Friedrich, Nele Ungeheuer, et al.
European Heart Journal|May 12, 2009
A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathyFelix W Friedrich, Pedro Bausero, Yuli Sun, et al.
Circulation|March 11, 2009
Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunctionSabine J van Dijk, Dennis Dooijes, Cris dos Remedios, et al.
Circulation|April 23, 2003
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategyPascale Richard, Philippe Charron, Lucie Carrier, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 4, 2014
Automated analysis of contractile force and Ca2+ transients in engineered heart tissueAndrea Stoehr, Christiane Neuber, Christina Baldauf, et al.
Autophagy|November 30, 2020
A high-throughput screening identifies ZNF418 as a novel regulator of the ubiquitin-proteasome system and autophagy-lysosomal pathwaySonia R Singh, Moritz Meyer-Jens, Erda Alizoti, et al.
Stem Cell Research|August 10, 2021
Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathyNele Warnecke, Bärbel M Ulmer, Sandra D Laufer, et al.
EMBO Molecular Medicine|May 30, 2013
Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in miceChristina Gedicke-Hornung, Verena Behrens-Gawlik, Silke Reischmann, et al.
Basic Research in Cardiology|December 15, 2015
Knock-out of nexilin in mice leads to dilated cardiomyopathy and endomyocardial fibroelastosisZouhair Aherrahrou, Saskia Schlossarek, Stephanie Stoelting, et al.
Circulation Research|April 11, 2020
Depletion of Vasohibin 1 Speeds Contraction and Relaxation in Failing Human CardiomyocytesChristina Yingxian Chen, Alexander K Salomon, Matthew A Caporizzo, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Cardiovascular Research|November 5, 2015
Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathyFrederik Flenner, Felix W Friedrich, Nele Ungeheuer, et al.
European Heart Journal|May 12, 2009
A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathyFelix W Friedrich, Pedro Bausero, Yuli Sun, et al.
Circulation|March 11, 2009
Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunctionSabine J van Dijk, Dennis Dooijes, Cris dos Remedios, et al.
Circulation|April 23, 2003
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategyPascale Richard, Philippe Charron, Lucie Carrier, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 4, 2014
Automated analysis of contractile force and Ca2+ transients in engineered heart tissueAndrea Stoehr, Christiane Neuber, Christina Baldauf, et al.
Autophagy|November 30, 2020
A high-throughput screening identifies ZNF418 as a novel regulator of the ubiquitin-proteasome system and autophagy-lysosomal pathwaySonia R Singh, Moritz Meyer-Jens, Erda Alizoti, et al.
Stem Cell Research|August 10, 2021
Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathyNele Warnecke, Bärbel M Ulmer, Sandra D Laufer, et al.
EMBO Molecular Medicine|May 30, 2013
Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in miceChristina Gedicke-Hornung, Verena Behrens-Gawlik, Silke Reischmann, et al.
Basic Research in Cardiology|December 15, 2015
Knock-out of nexilin in mice leads to dilated cardiomyopathy and endomyocardial fibroelastosisZouhair Aherrahrou, Saskia Schlossarek, Stephanie Stoelting, et al.
Circulation Research|April 11, 2020
Depletion of Vasohibin 1 Speeds Contraction and Relaxation in Failing Human CardiomyocytesChristina Yingxian Chen, Alexander K Salomon, Matthew A Caporizzo, et al.
Pageof 15